Top 40 Healthcare Transformers of 2018

Top 40 Healthcare Transformers of 2018

Here are the 40 upstarts and veterans who are transforming the healthcare industry.

Kevin Johnson, Marketeching

Kevin Johnson, Marketeching

Kevin Johnson is president of Marketeching.

Susan Dorfman, CMI/Compas

Susan Dorfman, CMI/Compas

Susan Dorfman is chief commercial officer of CMI/Compas.

Justin Chase, Intouch Solutions

Justin Chase, Intouch Solutions

Justin Chase is EVP and head, innovation and media at Intouch Solutions.

Anne Weiler, Wellpepper

Anne Weiler, Wellpepper

Anne Weiler is CEO and cofounder of Wellpepper.

Tej Toor, formerly Blink Health

Tej Toor, formerly Blink Health

Tej Toor was formerly product at Blink Health.

Sandra Shpilberg, Seeker Health

Sandra Shpilberg, Seeker Health

Sandra Shpilberg is founder and CEO of Seeker Health.

Scarlet Shore, Verily

Scarlet Shore, Verily

Scarlet Shore is product manager and platform lead, Project Baseline at Verily.

Omri Shor, Medisafe

Omri Shor, Medisafe

Omri Shor is CEO of Medisafe.

Sanjeev Saxena, POC Medical Systems

Sanjeev Saxena, POC Medical Systems

Sanjeev Saxena is CEO of POC Medical Systems.

Camille Samuels, Venrock

Camille Samuels, Venrock

Camille Samuels is partner of Venrock.

Colleen Reinhart, Edwards Lifesciences

Colleen Reinhart, Edwards Lifesciences

Colleen Reinhart is director, patient marketing and therapy awareness, transcatheter heart valves at Edwards Lifesciences.

Joe Meadows, Think Patients

Joe Meadows, Think Patients

Joe Meadows is president of Think Patients.

Chrissa McFarlane, Patientory

Chrissa McFarlane, Patientory

Chrissa McFarlane is founder and CEO of Patientory.

Molly McCarthy, Microsoft

Molly McCarthy, Microsoft

Molly McCarthy is national director, U.S. provider market and chief nursing officer of Microsoft.

Eddie Martucci, Akili Interactive Labs

Eddie Martucci, Akili Interactive Labs

Eddie Martucci is CEO of Akili Interactive Labs.

Missy Krasner, Amazon

Missy Krasner, Amazon

Missy Krasner is special projects/disruptive innovation at Amazon.

William King, Zephyr Health

William King, Zephyr Health

William King is founder and executive chairman of Zephyr Health.

John Jorden, Amgen

John Jorden, Amgen

John Jorden is executive director, Amgen Digital Health at Amgen.

Aaron Horowitz, Sproutel

Aaron Horowitz, Sproutel

Aaron Horowitz is cofounder and CEO of Sproutel.

Pablo Graiver, Antidote

Pablo Graiver, Antidote

Pablo Graiver is CEO of Antidote.

Jamey Edwards, Cloudbreak Health

Jamey Edwards, Cloudbreak Health

Jamey Edwards is CEO of Cloudbreak Health.

David Ebersman, Lyra Health

David Ebersman, Lyra Health

David Ebersman is cofounder and CEO of Lyra Health.

Nick Desai, Heal

Nick Desai, Heal

Nick Desai is cofounder and CEO of Heal.

Jeffrey Brewer, Bigfoot Biomedical

Jeffrey Brewer, Bigfoot Biomedical

Jeffrey Brewer is cofounder, president, and CEO of Bigfoot Biomedical.

Sundeep Bhan, Prognos

Sundeep Bhan, Prognos

Sundeep Bhan is cofounder and CEO of Prognos.

Jay Appel, Bristol-Myers Squibb

Jay Appel, Bristol-Myers Squibb

Jay Appel is executive director of Bristol-Myers Squibb.

Interview | Hans Kaspersetz, Arteric

Interview | Hans Kaspersetz, Arteric

Is technology causing agencies to become more specialized? Is there still a need for the human connection?

Sandoz signs on to lead launch of Pear's digital therapeutics

Sandoz signs on to lead launch of Pear's digital therapeutics

A deal with Sandoz to lead the global launch of Pear's two lead products puts marketing muscle behind the nascent class of 'prescription digital therapeutics.'

Crisis communicators give Zuckerberg high marks for testimony

Crisis communicators give Zuckerberg high marks for testimony

The Facebook CEO did not wilt during this week's marathon Senate session.

Facebook share price rebounds after Zuckerberg's testimony

Facebook share price rebounds after Zuckerberg's testimony

Despite the US Congress's lack of insight into Facebook's operations, Mark Zuckerberg's handling of the situation seems to have restored investor confidence in the company.

Interview | Scott Dulitz, TrialCard

Interview | Scott Dulitz, TrialCard

Scott Dulitz, SVP, Corporate Strategy, Business Development for TrialCard, outlines how embracing the modern hub allows brands to reach their full potential.

Johnson & Johnson marketing executive Debra Bass joins Nuvo

Johnson & Johnson marketing executive Debra Bass joins Nuvo

She will lead Nuvo Group's U.S. operations and head marketing globally.

Standing out in the era of value-based healthcare marketing

Standing out in the era of value-based healthcare marketing

With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.

HealthSpark 2018 unites disruptors at SXSW

HealthSpark 2018 unites disruptors at SXSW

AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed

Infographic | AI's impact on patients and caregivers

Infographic | AI's impact on patients and caregivers

Caregivers and patients predict how the use of AI will affect them.

Cannes Lions names new chairman

Cannes Lions names new chairman

Philip Thomas takes over from Terry Savage.

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.

MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.

What is a digital medicine, exactly? Akili co-founder Adam Gazzaley explains

What is a digital medicine, exactly? Akili co-founder Adam Gazzaley explains

MM&M spoke with Gazzaley about what's next for Akili, how he defines "digital medicine," and where the field is currently positioned on the hype cycle.

Rise of the health-tech ethicist

Rise of the health-tech ethicist

Want to get an ethicist agitated? Mention the integration of voice-activation and other tech into healthcare. Experts say navigating this area is a work in progress.

SXSW: Tech empathy, data skepticism, and a Black Eyed Pea fuel health track's surge

SXSW: Tech empathy, data skepticism, and a Black Eyed Pea fuel health track's surge

Health's popularity at SXSW continues to build. Here's our opening weekend wrap-up.

Pharma CMO: Why We're Being Blinded by Our Brands

Pharma CMO: Why We're Being Blinded by Our Brands

Recently, Forbes ran an article from Wild Pixel Media founder and CEO Carlos Machicao lamenting the fact that healthcare advertising is boring.

Can a nonprofit make generics great again?

Can a nonprofit make generics great again?

Acquisitions that were applauded a few years ago, such as Teva's purchase of Allergan's generic business, now look like lemons.

From Muse: Michelle Obama on making consumers comfortable with med tech (and thinking before she tweets)

From Muse: Michelle Obama on making consumers comfortable with med tech (and thinking before she tweets)

The former first lady spoke at Klick Health's Muse event, which also featured panels on gene therapy, health technology, and immunotherapy.

The doctor is always in as Heal CEO aims to revolutionize the healthcare sector

The doctor is always in as Heal CEO aims to revolutionize the healthcare sector

Heal CEO Nick Desai aims to improve the patient experience by providing an on-demand service that cuts time and costs while increasing human interaction.

First understanding, next adherence? Using VR to help kids visualize medical findings

First understanding, next adherence? Using VR to help kids visualize medical findings

Boston Children's Hospital and Klick Health are unveiling a VR tool to help pediatric patients visualize their disease and symptoms. It could augment the paper-based standard of care.

Finn Partners named AOR for cancer social network Belong.Life

Finn Partners named AOR for cancer social network Belong.Life

The platform is looking to focus its communications strategy on the U.S. market.

Virta Health CEO Sami Inkinen on changing patient behavior: 'We're cutting down trees in the wrong forest'

Virta Health CEO Sami Inkinen on changing patient behavior: 'We're cutting down trees in the wrong forest'

Seven questions for the Virta Health chief executive and cofounder of Trulia.

Machine Learning Helps Marketers

Machine Learning Helps Marketers

For some, the term machine learning may conjure up images of virtual assistants or automated tools.

Medtronic hires Gregory Zimprich as financial comms director

Medtronic hires Gregory Zimprich as financial comms director

Zimprich joins from Honeywell, where he led global business communications.

Did Congress just kill the Orphan Drug Act?

Did Congress just kill the Orphan Drug Act?

By allowing companies to claim a 50% tax credit for qualified clinical testing expenses, developing drugs for rare diseases became economically feasible for the first time.

Real-world evidence: It's finally having its moment

Real-world evidence: It's finally having its moment

Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.

Somatix picks Finn Partners as marcomms AOR

Somatix picks Finn Partners as marcomms AOR

Somatix is a digital health platform that tracks movements through smartwatches.

We Save Lives While Our Critics Complain

We Save Lives While Our Critics Complain

In his first press conference as president-elect, Donald Trump insisted pharma was "getting away with murder" due to expensive drug prices.

Goodbye, YouTube. Regulations could prompt microinfluencer migration to other platforms

Goodbye, YouTube. Regulations could prompt microinfluencer migration to other platforms

Some microinfluencers see the latest YouTube guidelines as a "slap in the face."

Google: slow mobile pages will hurt your ranking

Google: slow mobile pages will hurt your ranking

Advertisers have until July to get their mobile pages up to speed.

Five things for pharma marketers to know: Wednesday, January 17, 2018

Five things for pharma marketers to know: Wednesday, January 17, 2018

Celgene reportedly in talks to buy Juno; Novartis' Kymriah receives fast-track reviews in U.S. and Europe; BI's Gilotrif gets expanded approval in lung cancer

No Female Keynotes at CES but Alexa's Voice was Heard Above All Others

No Female Keynotes at CES but Alexa's Voice was Heard Above All Others

The tech that's most likely to survive post-CES hype is voice but brands should rethink their gendered approach.

Can digital tools really change patient behavior?

Can digital tools really change patient behavior?

New research calls into question the behavioral effects of some digital health tools.

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Five things for pharma marketers to know: Wednesday, January 10, 2018

Five things for pharma marketers to know: Wednesday, January 10, 2018

Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict

No Google, no problem: Pharma partners with China's tech giants

No Google, no problem: Pharma partners with China's tech giants

In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China's tech giants to snare a slice of a more than $100 billion market

MM&M launches 2018 search for Healthcare Transformers and Innovation Catalysts

MM&M launches 2018 search for Healthcare Transformers and Innovation Catalysts

MM&M is calling for nominations for the 2018 class of Top 40 Healthcare Transformers and is seeking industry input for the Top 10 Innovation Catalysts.

How healthbots can assist patients and HCPs

How healthbots can assist patients and HCPs

As HCPs continue to be stretched for time to diagnose and interact with patients, health bots could help reduce HCP workload and drive patient engagement.

Bank brand creates own algorithm to avoid YouTube ad pitfalls

Bank brand creates own algorithm to avoid YouTube ad pitfalls

US bank JPMorgan Chase has returned to advertising on YouTube only after developing its own algorithm that ensures its ads are not placed around questionable content.

MM&M's 5 most-read technology stories of 2017

MM&M's 5 most-read technology stories of 2017

Digital innovation in Japan, health-tech trends, and social media top the list.

Five things for pharma marketers to know: Wednesday, December 27, 2017

Five things for pharma marketers to know: Wednesday, December 27, 2017

Mallinckrodt to buy Sucampo for $1.2 billion; Amazon pushes digital advertising in 2018; WHO classifies gaming disorder as mental health condition

MM&M 2018 staff predictions: From gift bans to Google Assistant

MM&M 2018 staff predictions: From gift bans to Google Assistant

From gift bans to Google Assistant, POC to OPDP, MM&M staff members give their predictions on what to expect in healthcare marketing in 2018

Five things for pharma marketers to know: Thursday, December 14, 2017

Five things for pharma marketers to know: Thursday, December 14, 2017

Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer's biosimilar to J&J's Remicade; Novartis to downsize generics business

Gottlieb Eyes Prices, Not Lives

Gottlieb Eyes Prices, Not Lives

It turns out the real goal is going after Washington's favorite whipping boy — high drug prices.

Rejuvenan Global Health names Hudson Cutler communications AOR

Rejuvenan Global Health names Hudson Cutler communications AOR

The digital health startup was founded in 2015.

Five things for pharma marketers to know: Friday, December 8, 2017

Five things for pharma marketers to know: Friday, December 8, 2017

FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance

GCI Health puts Edie DeVine in charge of medical, health tech

GCI Health puts Edie DeVine in charge of medical, health tech

DeVine will oversee the agency's health IT and medical device work.

Lighthouse wins grand prize for voice-activated diabetes app at Hitlab

Lighthouse wins grand prize for voice-activated diabetes app at Hitlab

Lighthouse received $50,000 for application aimed at providing more accessible and engaging care for those living with diabetes.

What happens as marketers shift from algorithms to AI and other 2018 predictions

What happens as marketers shift from algorithms to AI and other 2018 predictions

Next year will be the start of the shift from marketing algorithms to AI, predicts Kantar Millward Brown.

Experts weigh in: How will health technology advance in 2018?

Experts weigh in: How will health technology advance in 2018?

Innovation-minded executives share their thoughts and predictions for the year ahead.

Five things for pharma marketers to know: Tuesday, December 5, 2017

Five things for pharma marketers to know: Tuesday, December 5, 2017

Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds

GroupM unveils upbeat global adspend forecast for 2018

GroupM unveils upbeat global adspend forecast for 2018

GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.

Five things for pharma marketers to know: Monday, December 4, 2017

Five things for pharma marketers to know: Monday, December 4, 2017

CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate

Five things for pharma marketers to know: Friday, December 1, 2017

Five things for pharma marketers to know: Friday, December 1, 2017

FDA approves first Apple Watch health accessory; medical charity shared data with pharma donors; FDA approves opioid-addiction treatment

Five things for pharma marketers to know: Thursday, November 30, 2017

Five things for pharma marketers to know: Thursday, November 30, 2017

FDA releases information on Exondys 51; Sanofi's dengue vaccine faces new restrictions; Kellyanne Conway named opioid czar

Amazon sets its sights on healthcare

Amazon sets its sights on healthcare

How worried should the industry's other major players be?

Facebook explains advertising policies to its users but industry wants more

Facebook explains advertising policies to its users but industry wants more

Facebook has formally outlined is advertising policies to its users but the industry feels the internet giant is offloading responsibility instead of stepping up.

How working with Apple inspired Jeff Tangney to found Doximity

How working with Apple inspired Jeff Tangney to found Doximity

The CEO's experience launching medical reference app Epocrates led him to found a social network for physicians.

Looking Beyond Overall Survival

Looking Beyond Overall Survival

Our understanding of how cancer develops and thrives has grown.

First 'Digital Drug' Faces a Second Litmus Test: Improving Adherence

First 'Digital Drug' Faces a Second Litmus Test: Improving Adherence

Technology like this could expand further to form better collaborations between pharma, payers and organized providers.

What does Twitter's 280 characters mean for pharma?

What does Twitter's 280 characters mean for pharma?

Marketers survey the pluses and minuses of the platform's new 280-character limit.

Five things for pharma marketers to know: Thursday, November 2, 2017

Five things for pharma marketers to know: Thursday, November 2, 2017

Teva reports lower-than-expected Q3 earnings; BI and Dicerna partner in NASH drug development; AstraZeneca's experimental asthma drug fails in Phase-III

Who's Getting Rich in Healthcare?

Who's Getting Rich in Healthcare?

Do you recall what President Trump tweeted right after Merck's Kenneth Frazier resigned from his American Manufacturing Council?

Wellpepper wins Alexa Diabetes Challenge

Wellpepper wins Alexa Diabetes Challenge

The health startup's system has a foot scanner that can take photos of a patient's feet and can look for potential foot ulcers using a machine learning image classifier.

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.

AI Drug Design Could Save Lives

AI Drug Design Could Save Lives

AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.

Ready or not, Amazon is Coming

Ready or not, Amazon is Coming

The e-giant is reportedly doing everything from starting secret labs and online pharmacies to redefining the hospital experience and democratizing health data.

One-quarter of global marketers report digital ads next to extremist content

One-quarter of global marketers report digital ads next to extremist content

Some of the world's marketers have reported specific examples of where their digital advertising appeared alongside offensive and compromising content.

How Pablo Graiver plans to solve the problem of clinical-trial recruitment

How Pablo Graiver plans to solve the problem of clinical-trial recruitment

The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.

Online patient communities consider the platform: Facebook, or somewhere more private?

Online patient communities consider the platform: Facebook, or somewhere more private?

Facebook itself has more than six million health-related groups.

Accessible website design for users with disabilities lags far behind demand

Accessible website design for users with disabilities lags far behind demand

Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.